Real ChatGPT answer · index seedfrizm1QdAxAcompleteHealth and wellness · supplements and vitaminscommercial
What form of niacin is recommended for managing high LDL cholesterol without causing severe flushing, and what are the liver enzyme monitoring protocols?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What form of niacin is recommended for managing high LDL cholesterol without causing severe flushing, and what are the liver enzyme monitoring protocols?
2 real searches · 1 real-search pass
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 2 queries…
Searches and sources
ChatGPT2 real searches · gpt-6
prescription extended-release niacin Niaspan prescribing information liver function tests every 6 to 12 weeks first year Google ↗
niacin LDL cholesterol guideline outcome benefit statin AIM-HIGH HPS2-THRIVE hepatotoxicity sustained release formulation Google ↗
- These highlights do not include all the information needed to use NIASPAN safely and effectively. See full prescribing information for NIASPAN. NIASPAN (niacin extended-release) tablet, film coated, extended release for oral use. Initial U.S. Approval: 1997 ® · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use NIACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for NIACIN EXTENDED-RELEASE TABLETS. NIACIN extended-release tablets USP, film coated, for oral useInitial U.S. Approval: 1997 · dailymed.nlm.nih.gov
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · ahajournals.org
- Niacin · ods.od.nih.gov
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · doi.org
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
prescription extended-release niacin Niaspan prescribing information liver function tests every 6 to 12 weeks first year OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
niacin LDL cholesterol guideline outcome benefit statin AIM-HIGH HPS2-THRIVE hepatotoxicity sustained release formulation OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |